We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$150M
AUM Growth
-$14.4M
Cap. Flow
-$5.61M
Cap. Flow %
-3.74%
Top 10 Hldgs %
87.14%
Holding
55
New
1
Increased
10
Reduced
3
Closed
5

Top Buys

Rank Stock Value
1
EQM
EQM Midstream Partners, LP
EQM
+$1.8M
2
KALV
KalVista Pharmaceuticals
KALV
+$485K
3
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$415K
4
MYGN icon
Myriad Genetics
MYGN
+$291K
5
CELG
Celgene Corp
CELG
+$188K

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$7.78M
2
ATRA icon
Atara Biotherapeutics
ATRA
+$402K
3
VCYT icon
Veracyte
VCYT
+$399K
4
NKTR icon
Nektar Therapeutics
NKTR
+$338K
5
APLS
Apellis Pharmaceuticals
APLS
+$203K

Sector Composition

Rank Sector Weight
1 Healthcare 96.12%
2 Energy 2.68%
3 Consumer Discretionary 0.06%
4 Materials 0.04%
5 Consumer Staples 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
51
DELISTED
Apellis Pharmaceuticals
APLS
– –
-8,000
Closed -$203K
ATRA icon
52
Atara Biotherapeutics
ATRA
$75.6M
– –
-800
Closed -$402K
EQT icon
53
EQT Corp
EQT
$30.8B
– –
-11,300
Closed -$179K
NKTR icon
54
Nektar Therapeutics
NKTR
$2.22B
– –
-633
Closed -$338K
ARRY
55
DELISTED
Array Biopharma Inc
ARRY
– –
-168,000
Closed -$7.78M
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Birchview Capital held 55 positions worth $150M, down 8.7% from $164M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Birchview Capital withdrew a net $5.61M in Q3 2019, closing 5 positions and reducing 3 holdings. Its most notable exit was Array Biopharma Inc, an estimated $7.78M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 97% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Birchview Capital opened a new position in KalVista Pharmaceuticals worth $348K.

  • Birchview Capital's largest Q3 2019 buy was KalVista Pharmaceuticals: 30,000 shares worth $348K.
  • Birchview Capital added most to EQM Midstream Partners, LP in Q3 2019, an estimated $1.8M increase.
  • Birchview Capital's biggest Q3 2019 reduction was Veracyte, cutting an estimated $399K.
  • Birchview Capital fully exited Array Biopharma Inc in Q3 2019, selling an estimated $7.78M.
  • Birchview Capital's ten largest holdings make up 87% of its $150M portfolio in Q3 2019.
  • Birchview Capital opened 1 new position and closed 5 in Q3 2019.
  • Birchview Capital's portfolio value fell 8.7% quarter-over-quarter to $150M.

Based on Birchview Capital's 13F filing for Q3 2019, filed 12 Nov 2019.